8/2/2021 2:09:14 AM
AstraZeneca Says Saphnelo Approved In The US For Moderate To Severe Systemic Lupus Erythematosus
7/29/2021 2:06:27 AM
AstraZeneca Posts H1 Revenue Growth Of 23% To $15.54 Bln
7/26/2021 2:05:08 AM
Alexion’ Ultomiris Recommended For Authorization In EU For Expanded Use To Include Children & Adolescents With PNH
7/23/2021 7:04:53 AM
AstraZeneca: FDA Approves BYDUREON BCise In US For Type 2 Diabetes In Patients Ages 10 Years And Older
7/19/2021 8:32:01 AM
Aridis Announces License Of Suvratoxumab, Phase 3-Ready Monoclonal Antibody, From AstraZeneca
7/19/2021 2:04:43 AM
AstraZeneca Says Imfinzi Approved In China For Extensive-stage Small Cell Lung Cancer
7/16/2021 2:13:41 AM
AstraZeneca: FDA Advisory Committee Does Not Recommend Roxadustat Approval In Anaemia Of CKD
7/14/2021 2:14:43 AM
AstraZeneca Gets Final Regulatory Clearance For Proposed Acquisition Of Alexion From UK's CMA